Release Date: 13/09/11 18:01 Summary: Half Year Accounts - 30 June 2011 Price Sensitive: No Download Document 1.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%